Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Infrared Light Technology May Open New Opportunities to Image Cancer, Tay Sachs Disease

By LabMedica International staff writers
Posted on 28 Sep 2010
A technique employing near-infrared light enables scientists to look deeper into the workings of cells, potentially creating a new tool in the fight against cancer and many other diseases.

University of Central Florida (UCF; Orlando, USA) chemists, led by Prof. More...
Kevin Belfield, used near infrared light and fluorescent dye to take pictures of cells and tumors deep within tissue. The probes specifically target lysosomes, which have been linked to a variety of diseases, including types of mental illnesses and cancers.The probes can be adapted to look for specific proteins found in tumors, which means they someday may help physicians diagnose and potentially treat tumors. "This is a game-changer,” Prof. Belfield said. "Until now, there was no real way to study lysosomes because existing techniques have severe limitations. But the probe we developed is stable, which allows for longer periods of imaging.”

Conventional imaging probes work for only a few minutes. They cannot penetrate deep tissue, are sensitive to pH levels, and have poor water solubility. Prof. Belfield's technique jumps over those hurdles by using near-infrared light. Once researchers identified the correct light frequency, they took images of lysosomes for hours. The new approach will allow researchers to see lysosomes at work and to piece together their role in diseases such as cancer and Tay-Sachs, a genetic disorder from which children typically die by age four.

"We've come up with something that should make a huge difference in finding answers to some very complicated conditions,” Prof. Belfield concluded.

The study's findings, which include comparisons to the only two existing probes on the market today, were published in the August 2010 issue of the Journal of the American Chemical Society.

Related Links:

University of Central Florida




Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The blood-based assay captures circulating chromatin, cell-free DNA fragments that are largely inaccessible through standard laboratory methods (image credit: Shuttertstock)

Blood-Based Assay Enables Noninvasive Monitoring of Sarcoma Immunotherapy Response

Sarcomas remain difficult to monitor during immunotherapy, as low tumor mutation burden can limit traditional circulating tumor DNA approaches and repeat tissue biopsies are often impractical in advanced disease.... Read more

Immunology

view channel
Image: New research shows that autoimmunity drives debilitating long COVID symptoms in a subset of patients (Image credit: Shutterstock)

Study Points to Autoimmune Pathway Behind Long COVID Symptoms

Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.